imatinib mesylate has been researched along with Female Genital Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Liu, W; Shuai, X; Tao, K; Wang, S; Zeng, X; Zhang, P | 1 |
| Dushkin, H; Schilder, RJ | 1 |
| Chen, SS; Chen, YZ; Hsu, S | 1 |
| Bogusław, L; Piotr, R; Wanda, M; Włodzimierz, R; Zbigniew, N | 1 |
1 review(s) available for imatinib mesylate and Female Genital Neoplasms
| Article | Year |
|---|---|
Imatinib mesylate and its potential implications for gynecologic cancers.
Topics: Benzamides; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Imatinib Mesylate; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Piperazines; Prognosis; Pyrimidines; Risk Assessment; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2005 |
3 other study(ies) available for imatinib mesylate and Female Genital Neoplasms
| Article | Year |
|---|---|
Primary Gastrointestinal Stromal Tumor Mimicking as Gynecologic Mass: Characteristics, Management, and Prognosis.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Ileum; Imatinib Mesylate; Jejunum; Laparoscopy; Length of Stay; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors | 2020 |
Gastrointestinal stromal tumors presenting as gynecological tumors.
Topics: Aged; Benzamides; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pyrimidines | 2006 |
[Gastrointestinal stromal tumors localized in small intestine and diagnosed preoperatively as gynecological neoplasms].
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Imatinib Mesylate; Intestine, Small; Middle Aged; Piperazines; Prognosis; Pyrimidines; Treatment Outcome | 2005 |